BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Embryo
,
Laryngoscope
,
Lipitor
,
rs3825942
,
NEUROG3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gaba
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
Drug target sets for approved compounds
Liver tissues from rats after treatment with different compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Disinhibition Is an Essential Network Motif Coordinated by GABA Levels and GABA B Receptors.
The Role of Extrasynaptic GABA Receptors in Postpartum Depression.
Interplay between microbial-derived GABA and host GABA receptor signaling collectively influence the…
Mechanistic insights into the selectivity of bicyclophosphorothionate antagonists for housefly versu…
Revisiting benzodiazepines (GABA Enhancers):A transdiagnostic and precision medicine approach.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
GABA and Beta-cell Regeneration
GABA Biomarkers in Dravet Syndrome
Intervention With a GABA Supplement in Prediabetics
Relative Oral Bioavailability of GABA From Tomatoes
GABA Treatment in Subjects With Type 1 Diabetes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ